about
Filamentous fungal infections in immunosuppressed patients: prophylaxis and treatmentEfficacy of nebulized liposomal amphotericin B in treatment of experimental pulmonary aspergillosisRifampin reduces concentrations of trimethoprim and sulfamethoxazole in serum in human immunodeficiency virus-infected patients.Causes of death in a contemporary cohort of patients with invasive aspergillosisSteady-state pharmacokinetics of a double-boosting regimen of saquinavir soft gel plus lopinavir plus minidose ritonavir in human immunodeficiency virus-infected adultsClinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retrosTreatment of invasive fungal infections in high-risk haematological patients: what have we learnt in the past 10 years?Clinical usefulness of therapeutic drug monitoring of voriconazole in a university hospital.Trends in AIDS and mortality in HIV-infected subjects with hemophilia from 1985 to 2003: the competing risks for death between AIDS and liver disease.Epidemiology and prognosis of candidaemia in elderly patients.Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain.Efficacy of β-Lactam/β-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia.Salvage Therapy with Ceftolozane-Tazobactam for Multidrug-Resistant Pseudomonas aeruginosa Infections.Imported Disease Screening Prior to Chemotherapy and Bone Marrow Transplantation for Oncohematological Malignancies.Galactomannan enzyme immunoassay and quantitative Real Time PCR as tools to evaluate the exposure and response in a rat model of aspergillosis after posaconazole prophylaxis.[Invasive yeast infections in neutropenic patients].Epidemiology of invasive respiratory disease caused by emerging non-Aspergillus molds in lung transplant recipients.10 years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology of Aspergillus spp. infection in lung transplantation.Burden of serious fungal infections in Spain.[Invasive mould disease in haematological patients].Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial.Antimicrobial resistance in Gram-negative rods causing bacteremia in hematopoietic stem cell transplant patients: intercontinental prospective study of Infectious Diseases Working Party of the European Bone Marrow Transplantation group.Unusual forms of subacute invasive pulmonary aspergillosis in patients with solid tumors.Environmental variables associated with an increased risk of invasive aspergillosis.Peginterferon alpha-2b plus ribavirin vs interferon alpha-2b plus ribavirin for chronic hepatitis C in HIV-coinfected patients.Valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipients.Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.Efficacy of high doses of liposomal amphotericin B in the treatment of experimental aspergillosis.[Potential of anidulafungin in hematological patients].[Antifungals for systemic use].[Efavirenz and nevirapine plasma levels in HIV-infected patients with hemophilia].[Guidelines for the treatment of Invasive Candidiasis and other yeasts. Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2010 Update].Guidelines for the prevention of invasive mould diseases caused by filamentous fungi by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC).[Recommendations of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the prevention of invasive fungal infection due to filamentous fungi].Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study.Pneumonia in allogeneic stem cell transplantation recipients: a multicenter prospective study.Effectiveness of antibiotic-lock therapy for long-term catheter-related bacteremia due to Gram-negative bacilli: a prospective observational study.Management of Infection and Febrile Neutropenia in Patients with Solid Cancer.Predictors of mortality and impact of aminoglycosides on outcome in listeriosis in a retrospective cohort study--authors' responseOsteomielitis vertebral por Candida spp
P50
Q26781218-0542DBE5-4889-4391-938C-608B197C023EQ33883785-9348F563-CE3B-4575-95D3-C335023037DFQ33983443-E46467A2-0E76-412C-9768-158CA11FB3C9Q35213770-2589661D-E842-46B9-AFD8-717BFBC82024Q37598597-4183A89B-6146-4C7D-9C77-5EA4FBF1DBBEQ37612207-86BC8F8D-76F5-42C2-98D7-1D1FD6E08642Q38176559-8045754B-CF85-41E4-972B-E77834A47383Q38280283-2F8745DA-D60F-4CDD-9165-E30E4C581B92Q38468519-DA567C6B-1BAA-49E1-B62E-E511626CCFF6Q40072606-C13C64AD-FDAF-48CE-8454-839E0AF50A22Q40143676-ACCE594B-3539-42B2-AEB5-3344C9A356EDQ40184233-5D994447-D764-4190-A187-54D9DD0B248EQ40412684-0B6723F9-1429-44FF-829C-B464BA02947DQ40419395-329E235B-92E1-45E4-9298-9E0F6CDC608DQ40492198-4471B731-24E3-478E-8E7E-D30C3686446CQ40619796-D0F91D7A-CA22-4ADA-8586-2C67FE25380FQ40867351-0828B1D2-01E3-42C7-888F-9F10F0B28EF0Q41015559-FC8DBC3A-0793-4A51-AB3F-F5E9FB27F84FQ41469398-D07B188C-8B29-46A0-8CF1-15543E420F21Q41642843-50C51429-5ED5-4D54-ACB2-8C4569FF70D4Q41692312-D017589B-B390-4A73-BEB0-97EC05EA9F14Q41987005-62F43011-B200-4D49-A9B1-BDA1EEB37090Q42214580-D70F2871-F966-4613-BFB0-50FEB1074746Q42217853-155F6634-593F-4FC3-A2DC-A28D73E8B6A6Q43036704-6F8D311F-D31A-41F4-BEBE-780277D24479Q44463320-C177134B-AFA3-4A84-8628-0343046375F6Q44548718-A762CFEC-13D8-4602-A520-EF9E53A3A46FQ44653264-006FA042-0CED-4424-86C9-88CB46F66353Q45942584-BE618E78-B7F9-4A0E-B943-71EA5794D20CQ45989494-424FC233-D5F9-4905-B91A-DE60893EC8F9Q46560049-6D526CFD-1718-4474-9723-76C4885E7BA1Q50541087-39EC63A6-4E88-432F-8528-60618A63E2D0Q51175770-8524C3B0-43C9-4626-A5FB-D09835E3003CQ51179904-C01F02C5-8674-46E3-802F-B581AF9D5B0AQ51232974-E5EBC95A-25A4-4399-ABE8-D3FD3782B262Q54346717-35F80BCC-5DCA-4BA1-B045-2DF826AE97A4Q54353729-8CDD82C8-EE50-4F8B-BC34-2ED6070BDFBDQ54788302-E4EA63A5-454D-4816-A322-C6262CF735EDQ56794104-67B35398-D76E-49BD-B7F2-0DC9A7764246Q56794136-241BDF79-21CE-4CA4-AEF2-1FD0B55C8770
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Isabel Ruiz
@ast
Isabel Ruiz
@en
Isabel Ruiz
@es
Isabel Ruiz
@nl
Isabel Ruiz
@sl
type
label
Isabel Ruiz
@ast
Isabel Ruiz
@en
Isabel Ruiz
@es
Isabel Ruiz
@nl
Isabel Ruiz
@sl
altLabel
Isabel Ruiz
@en
prefLabel
Isabel Ruiz
@ast
Isabel Ruiz
@en
Isabel Ruiz
@es
Isabel Ruiz
@nl
Isabel Ruiz
@sl
P106
P1153
16153658000
P21
P31
P496
0000-0003-3743-2379